Ribavirin nasal drops

Antiviral drug. It has the effect of inhibiting the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. This product does not change the adsorption, invasion and uncoating of viruses, nor does it induce the production of interferon. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

The main ingredient of this product is ribavirin, whose chemical name is 1-beta;-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide

This product is a colorless clear liquid.

Suitable for influenza.

Nose drops, 1 to 2 drops at a time, once every 1 to 2 hours.

Large-scale use of this product may produce the same adverse reactions as systemic medication. Common adverse reactions include anemia and fatigue, which disappear after stopping the drug. Less common adverse reactions include fatigue, headache, insomnia, loss of appetite, nausea, vomiting, mild diarrhea, constipation, etc., and may cause a decrease in red blood cells, white blood cells and hemoglobin.

It is forbidden for people who are allergic to this product and pregnant women.

Precautions for children: There is no reference for the use of this product in children. Precautions for pregnancy and lactation: It is not recommended for pregnant women. Lactating women should suspend breastfeeding when using it. Precautions for the elderly: It is not recommended for the elderly.

Large-scale use of this product may produce drug interactions similar to systemic medications, such as antagonism when used with zidovudine, because this product can inhibit the conversion of zidovudine into active zidovudine phosphate.

Keep tightly closed in a cool place.

8 ml: 40 mg

24 months

HeBei Wuluo Pharmaceutical Co., Ltd.

• Founded in:

  2006-03-15

• Address:

  No. 7, Zhongkuang Road, Hengde Industrial Park, Jing County, Hengshui City, Hebei Province

• Tax NO.:

  911311277870000031

• Registered Funds:

  50 million yuan

• Email:

  Log in to view